Cargando…
Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy
X-linked Charcot-Marie-Tooth disease type 1 (CMT1X) is a demyelinating neuropathy resulting from loss-of-function mutations affecting the GJB1/connexin 32 (Cx32) gene. We previously showed functional and morphological improvement in Gjb1-null mice following AAV9-mediated delivery of human Cx32 drive...
Autores principales: | Kagiava, Alexia, Karaiskos, Christos, Lapathitis, George, Heslegrave, Amanda, Sargiannidou, Irene, Zetterberg, Henrik, Bosch, Assumpció, Kleopa, Kleopas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460951/ https://www.ncbi.nlm.nih.gov/pubmed/37645436 http://dx.doi.org/10.1016/j.omtm.2023.07.011 |
Ejemplares similares
-
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy
por: Kagiava, Alexia, et al.
Publicado: (2021) -
Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021) -
Aberrant Mitochondrial Dynamics and Exacerbated Response to Neuroinflammation in a Novel Mouse Model of CMT2A
por: Stavropoulos, Filippos, et al.
Publicado: (2021) -
Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease
por: Olympiou, Margarita, et al.
Publicado: (2016) -
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice
por: Stavrou, Marina, et al.
Publicado: (2022)